Integrated Wealth Concepts’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Integrated Wealth Concepts's TXG Position: Q2 2026 in Review
Integrated Wealth Concepts increased its 10x Genomics (TXG) stake by 35% in Q2 2026, buying an estimated $147K and bringing the position to 21,645 shares worth $830K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.
Integrated Wealth Concepts first reported a position in TXG in Q2 2025 and has held it in 3 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Integrated Wealth Concepts held 21,645 shares of 10x Genomics worth $830K as of Q2 2026.
- Integrated Wealth Concepts bought 5,595 10x Genomics shares in Q2 2026, an estimated $147K.
- 10x Genomics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1457 holding.
- Integrated Wealth Concepts first reported a position in 10x Genomics in Q2 2025 and has held it in 3 quarters since.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.